Telmisartan and Pomalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Telmisartan (telmisartan) and Pomalidomide (pomalidomide). Common drug interactions include arthralgia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Telmisartan and Pomalidomide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.



On Jul, 26, 2026

16 people who take Telmisartan and Pomalidomide together, and have interactions are studied.

Telmisartan and Pomalidomide drug interactions.

What are the common drug interactions of Telmisartan and Pomalidomide, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Blood pressure systolic increased
  4. Chest pain
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Dry skin
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Heart rate increased
  10. Muscle spasms (muscle contraction)

male:

  1. Asthenia (weakness)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Tongue biting
  4. Vitamin b12 deficiency
  5. White blood cell count decreased
  6. Arthralgia (joint pain)
  7. Chest pain
  8. Conjunctival haemorrhage (bleeding underneath the conjunctiva)
  9. Dyspnoea (difficult or laboured respiration)
  10. Genital infection fungal

What are the common drug interactions of Telmisartan and Pomalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Arthralgia (joint pain)
  2. Chest pain
  3. Muscle spasms (muscle contraction)
  4. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Peripheral coldness
  7. Plasma cell myeloma (cancer that begins in plasma cells)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Rash
  10. Vision blurred

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 13 people, 81.25%
  2. Sleep Disorder: 5 people, 31.25%
  3. Heart Rate Increased: 5 people, 31.25%
  4. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 5 people, 31.25%
  5. Diarrhea: 4 people, 25.00%
  6. Urinary Tract Infection: 3 people, 18.75%
  7. N-Terminal Prohormone Brain Natriuretic Peptide Increased: 3 people, 18.75%
  8. Cytomegalovirus Infection: 3 people, 18.75%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 18.75%
  10. Dry Eyes (lack of adequate tears): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and Pomalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Telmisartan and Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Telmisartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pomalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and pomalidomide (the active ingredients of Telmisartan and Pomalidomide, respectively), and Telmisartan and Pomalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: